UTAH MEDICAL PRODUCTS INC
Close on Oct 19, 2026
- Market cap
- $237.37M
- P/E (TTM)
- 22.7
- Dividend yield
- –
Earnings
Next report expected Oct 22, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 23, 2026 | During market hours | $8.53M | $0.84 | – |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 23, 2026 | During market hours | $8.72M | $0.82 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Jan 29, 2026 | During market hours | $9.04M | $0.80 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 23, 2025 | During market hours | $9.81M | $0.82 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 24, 2025 | During market hours | $9.95M | $0.94 | – |
| Q1 FY2025 Ended Mar 31, 2025 | Apr 29, 2025 | During market hours | – | $0.92 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Jan 28, 2025 | During market hours | $9.16M | $0.86 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 30, 2024 | During market hours | $12.33M | $1.18 | – |
| Q3 FY2023 Ended Sep 30, 2023 | Oct 26, 2023 | During market hours | – | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Jul 25, 2023 | During market hours | – | – | – |
| Q1 FY2023 Ended Mar 31, 2023 | Apr 25, 2023 | After market close | – | – | – |
Company guidance
Outlook given with results on Jul 23, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| litigation expenses | 2026 | $1.60M | New |
| sales decline | year 2026 | -13% to -10% growth | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Utah Medical Products filed with the SEC
PRESS RELEASE ISSUED AUGUST 31, 2026: FEMCARE LTD ACQUIRES ORION MEDICAL SUPPLIES LTD IN THE UK
Regulation FD disclosure · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Year 2025 and Fourth Quarter Financial Performance
Results of operations · EX-99.1 to Form 8-K
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
Executive or director change · Other events · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025
Results of operations · EX-99.1 to Form 8-K
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Year 2024 and Fourth Quarter Financial Performance
Results of operations · EX-99.1 to Form 8-K
UTAH MEDICAL PRODUCTS, INC. APPOINTS NEW DIRECTOR AND INCREASES QUARTERLY CASH DIVIDEND
Executive or director change · Other events · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
Results of operations · EX-99.1 to Form 8-K
UTAH MEDICAL PRODUCTS, INC. INCREASES REGULAR QUARTERLY DIVIDEND
Other events · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023
Results of operations · EX-99.1 to Form 8-K
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
Results of operations · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
Results of operations · EX-99.1 to Form 8-K
FINANCIAL INFORMATION FOR UTAH MEDICAL PRODUCTS, INC.
Results of operations · EX-99.1 to Form 8-K
Utah Medical Products, Inc. Announces Quarterly Dividend
Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED FEBRUARY 1, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED NOVEMBER 2, 2021
Other events · EX-99.1 to Form 8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2021
Results of operations · EX-99.1 to Form 8-K